Prospective dynamic sampling and molecular residual disease monitoring to predict clinical outcomes for patients with unresectable, locally advanced non-small cell lung cancer undergoing radical radiotherapy.

Authors

null

Jia-Tao Zhang

Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

Jia-Tao Zhang , Yi Pan , Xuan Gao , Zhi-yong Chen , Bingfa Yan , Pei-Xin Tan , Xiao-Rong Yang , Hui Lin , Hong-Hong Yan , Song Dong , Bin-Chao Wang , Jin-Ji Yang , Hai-Yan Tu , Xue-Ning Yang , Wenzhao Zhong , Xuefeng Xia , Xin Yi , Qing Zhou , Yi-Long Wu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 8549)

DOI

10.1200/JCO.2023.41.16_suppl.8549

Abstract #

8549

Poster Bd #

176

Abstract Disclosures

Similar Posters

First Author: Kirby P Gardner

First Author: Edward D. Esplin

Poster

2024 ASCO Gastrointestinal Cancers Symposium

NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-NORTH AMERICA).

NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-NORTH AMERICA).

First Author: Christopher Hanyoung Lieu